Generative Bionics S.R.L
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Generative Bionics S.R.L - overview
Established
2025
Location
Genoa, Liguria, Italy
Primary Industry
Medical Devices & Equipment
About
Generative Bionics S. R. L, located in Genoa, Italy, specializes in developing advanced humanoid robot companions that enhance human interactions across various settings, including healthcare, education, and personal assistance. Based in Liguria, Italy and founded in 2024, Generative Bionics S.
r. l. , founded by Daniele Pucci, who also serves as CEO, along with co-founders Alessio Del Bue, Marco Maggiali, and Andrea Pagnin, provides intelligent humanoid robotic systems powered by physical AI for the robotics and advanced manufacturing industry. In December 2025, Generative Bionics S.
R. L raised EUR 70 million in venture funding led by new investor CDP Venture Capital, with participation from other new investors AMD Ventures, Duferco, Eni Next, RoboIT, and Tether International, S. A. de C.
V. Other unspecified investors also participated in the round. Generative Bionics S. R.
L. specializes in developing intelligent humanoid robot companions designed to enhance human potential and interaction. Their core products focus on creating advanced robotic systems that serve as companions in various environments, including healthcare, education, and personal assistance. These humanoid robots are equipped with sophisticated artificial intelligence that allows them to interact with users in a meaningful way, addressing needs such as companionship for the elderly, educational support for children, and assistance for individuals with disabilities.
Generative Bionics targets diverse geographical markets, including Europe and North America, catering to both personal and institutional clients, such as healthcare facilities, educational institutions, and individual consumers seeking technological solutions. The revenue model of Generative Bionics encompasses several transactional structures, including direct-to-consumer sales and B2B partnerships with institutions. Clients typically engage in purchasing or leasing arrangements for their humanoid robot companions, enabling them to integrate these technologies into their operations or personal lives effectively. The pricing structure may vary based on the complexity and capabilities of the specific robotic systems, often involving subscription plans for ongoing support and maintenance services.
Their flagship offerings are designed to provide comprehensive solutions tailored to the unique needs of clients, facilitating enhanced user experience and satisfaction. The company will use the December 2025 funding to develop physical artificial intelligence and edge artificial intelligence systems and support the industrial validation and production of its humanoid platform.
Current Investors
CDP Venture Capital, AMD Ventures, Eni Next
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Monitoring Equipment
Website
www.gbionics.ai/
Verticals
Artificial Intelligence, Robotics
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Generative Bionics S.R.L - financials
| Fiscal Year Ended | Dec 31, 2025 |
|---|---|
| Revenue (USD) | - |
| % Revenue Growth (YoY) | - |
| EBITDA (USD) | - |
| Operating Income (USD) | - |
| Operating Margin | - |
| % EBITDA Margin | - |
| NET Income (USD) | - |
| % Net Margin | - |

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.